half-dose ticagrelor
ACS-3
Approved small_molecule active
Quick answer
half-dose ticagrelor for Acute Coronary Syndrome is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Acute Coronary Syndrome
- Phase
- Approved
- Modality
- small_molecule
- Status
- active